The newest Quarterly Newsletter was released today. The four-page newsletter discusses the clinical and business aspects relating to our events in Quarter 3, 2011:

• Expanding CellerateRX® Marketing Efforts
  • Read about the new marketing channels being used to increase the brand awareness of CellerateRX
• New Clinical Studies at celleraterx.com
  • Two new clinical studies are now online
• Medical Conferences Play Important Role in Q3 Development
  • Three important conferences were held: The Clinical Symposium on Advances in Skin & Wound Care (September 9-12, National Harbor, MD), AdvaMed 2011: The MedTech Conference (September 28, Washington, D.C.), and The Symposium on Advanced Wound Care “SAWC” Fall 2011 (October 13-15, Las Vegas, NV).
• New Wound Care Nurse Testimonial
  • Read a wound care nurse relate her experience using CellerateRX
• Clinicians' Conversations
  • Join up for an upcoming webinar to learn more about CellerateRX® Activated Collagen®
• Research Coverage Initiated by OneMedPlace
  • See detailed research on our company
    

The four-page newsletter discusses the clinical and business aspects relating to our events in Quarter 2, 2011:

• CellerateRX and its Effectiveness in Dermatological Procedures
  • Hear the testimonial of a man who saw success with CellerateRX gel after a precancerous skin removal procedure
• New Website Launched
  • Find out the new features of www.wmgtech.com
• White Paper discussing Skin Tears and CellerateRX
  • Have a 1st or 2nd degree burn? You'll want to read this white paper.
• Article Discussing Repositioning to Reduce Pressure Ulcers
  • An analysis of a common issue
• Organized List of Quarterly Press Releases and Business News
  • Read a synopsis of our business happenings which cover topics such as: CellerateRX Commercials on Fox News, Q1 Results Filed Record Revenue Reported with Cash Position at All-Time High, the Agreements Signed in Q2, and more!
• Letter to Shareholders
  • See the highlights of Deborah Jenkins Hutchinson's Letter to Shareholders